BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10559615)

  • 41. Observation versus adjuvant radiation or chemotherapy in the management of stage I seminoma: clinical outcomes and prognostic factors for relapse in a large US cohort.
    Soper MS; Hastings JR; Cosmatos HA; Slezak JM; Wang R; Lodin K
    Am J Clin Oncol; 2014 Aug; 37(4):356-9. PubMed ID: 23275274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
    Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A risk-adapted strategy of radiotherapy or cisplatin-based chemotherapy in stage II seminoma.
    Domont J; Massard C; Patrikidou A; Bossi A; de Crevoisier R; Rose M; Wibault P; Fizazi K
    Urol Oncol; 2013 Jul; 31(5):697-705. PubMed ID: 21665493
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Results of radiotherapy for 230 patients with stage I-II seminomas.
    Hültenschmidt B; Budach V; Genters K; Sack H
    Strahlenther Onkol; 1996 Apr; 172(4):186-92. PubMed ID: 8623080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognosis of primary testicular seminoma: a report on 57 new cases.
    Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
    Cancer Res; 2000 Apr; 60(8):2152-4. PubMed ID: 10786678
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Seminoma arising in corrected and uncorrected inguinal cryptorchidism: treatment and prognosis in 66 patients.
    Li YX; Coucke PA; Qian TN; Huang YR; Gu DZ; Mirimanoff RO; Yu ZH
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):343-50. PubMed ID: 9226322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Should an elevated human chorionic gonadotropin titer alter therapy for seminoma?
    Swartz DA; Johnson DE; Hussey DH
    J Urol; 1984 Jan; 131(1):63-5. PubMed ID: 6690749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.
    Stevens MJ; Norman AR; Dearnaley DP; Horwich A
    J Clin Oncol; 1995 Jan; 13(1):87-92. PubMed ID: 7528272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum lactate dehydrogenase isoenzyme 1 in patients with seminoma stage I followed with surveillance.
    von Eyben FE; Madsen EL; Blaabjerg O; Petersen PH; Jacobsen GK; Specht L; Pedersen BN; von der Maase H
    Acta Oncol; 2002; 41(1):77-83. PubMed ID: 11990523
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Radiotherapy for stages I and IIA/B testicular seminoma.
    Bamberg M; Schmidberger H; Meisner C; Classen J; Souchon R; Weinknecht S; Schorcht J; Walter F; Engenhart-Cabillic R; Schulz U; Born H; Flink M
    Int J Cancer; 1999 Dec; 83(6):823-7. PubMed ID: 10597202
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pitfalls of hCG monitoring in stage I seminoma.
    Wylie JP; Logue JP
    Clin Oncol (R Coll Radiol); 1998; 10(2):131-2. PubMed ID: 9610904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Management of advanced seminoma: retrospective study of 96 patients].
    Bompas E; Fléchon A; Biron P; Droz JP
    Bull Cancer; 2002 Oct; 89(10):877-85. PubMed ID: 12441279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients.
    Mencel PJ; Motzer RJ; Mazumdar M; Vlamis V; Bajorin DF; Bosl GJ
    J Clin Oncol; 1994 Jan; 12(1):120-6. PubMed ID: 7505805
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term outcomes of radiotherapy for stage II testicular seminoma--the Mayo Clinic experience.
    Hallemeier CL; Pisansky TM; Davis BJ; Choo R
    Urol Oncol; 2013 Nov; 31(8):1832-8. PubMed ID: 22537538
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical study of testicular tumor: tumor tissue content of hCG in seminoma].
    Sugawara T
    Nihon Hinyokika Gakkai Zasshi; 1989 Jun; 80(6):847-55. PubMed ID: 2796103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Management of chorionic gonadotropin-producing seminoma].
    Boujelbene N; Ozsahin M; Ugurluer G; Gaye MP; Mirimanoff RO; Zouhair A
    Prog Urol; 2011 May; 21(5):308-13. PubMed ID: 21514532
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Testicular cancer treated in a minor general oncology department.
    Norum J; Nordøy T; Wist E
    Eur J Cancer; 1995; 31A(3):293-5. PubMed ID: 7540400
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Significance of simultaneous determination of serum human chorionic gonadotropin (hCG) and hCG-beta in testicular tumor patients.
    Hoshi S; Suzuki K; Ishidoya S; Ohyama C; Sato M; Namima T; Saito S; Orikasa S
    Int J Urol; 2000 Jun; 7(6):218-23. PubMed ID: 10843453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Testicular seminoma: analysis of treatment and failure for stage II disease.
    Evensen JF; Fossa SD; Kjellevold K; Lien HH
    Radiother Oncol; 1985 Aug; 4(1):55-61. PubMed ID: 4035002
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance.
    Warde P; Gospodarowicz MK; Banerjee D; Panzarella T; Sugar L; Catton CN; Sturgeon JF; Moore M; Jewett MA
    J Urol; 1997 May; 157(5):1705-9; discussion 1709-10. PubMed ID: 9112510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.